Three prospective human studies report micro‑ and nanoplastic (MNP) detection in coronary blood, cardiopulmonary bypass–exposed blood, and carotid atheroma; associations with inflammation and adverse cardiovascular events raise biologic plausibility but do not yet prove causation.